Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 12/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 11/20 | 0.41 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 4/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.37 |
| ▸ | NPY2R | P49146 | 1/20 | 0.37 |
| ▸ | NPY4R | P50391 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17706450 | 0.92 | SIRT2 (0.41) | SIRT2SIRT1SIRT3SIRT5NPY1R | |
| SCHEMBL26560488 | 0.88 | FAP (0.39) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL23189216 | 0.87 | FAP (0.39) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL26140860 | 0.87 | FAP (0.39) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL24584968 | 0.87 | FAP (0.39) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL24774254 | 0.87 | FAP (0.39) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL20043710 | 0.87 | SIRT2 (0.46) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL23347054 | 0.86 | SIRT2 (0.45) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL17683439 | 0.86 | SIRT2 (0.45) | SIRT2SIRT1SIRT3SIRT5 | |
| SCHEMBL24540901 | 0.85 | SIRT2 (0.36) | SIRT2SIRT1SIRT3SIRT5NPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023083900-A1 | CONJUGATES COMPRISING A PHOSPHORUS (V) AND A DRUG MOIETY | TUBULIS GMBH (DE) | 2023-05-19 | — | — | WO | disclosed |